JOHNNEL PAHILA

Clinical Trial Sub-Investigator

Quezon City, National Capital Region, Philippines

About

Dynamic and compassionate medical professional with a growing background in clinical research and a passion for both healthcare and entrepreneurship. Seeking to leverage medical expertise and leadership in innovative, people-centered environments.

Experience

  • Business Owner at Espresso Studio Coffee Shop
    Feb 2025 - Present · 1 yr 6 mos

    The Owner of Espresso Studio is responsible for overseeing the entire operation, from strategic planning and daily operations to staff management and financial oversight. This role combines entrepreneurial leadership with a passion for coffee and community engagement.

  • Parexel (Philippines · On-site)
    • Sub-investigator (Clinical Trials)
      2024 - Present · 2 yrs 7 mos

      Supports the Principal Investigator (PI) in the conduct of clinical trials, ensuring that the study is carried out according to the protocol, Good Clinical Practice (GCP), ethical standards, and regulatory requirements. Performs clinical evaluations, obtain informed consent, manage trial-related procedures, and contribute to the accurate and timely documentation of study data. Plays a special role in enhancing site-specific operational procedures and clinical algorithms to ensure efficiency, compliance, and continuous quality improvement at the trial site.

    • Clinical Research Physician
      Jan 2023 - 2025 · 2 yrs 1 mo

      A licensed healthcare professional, trained in GCP and relevant regulatory guidelines, who supports the Principal Investigator (PI) in the execution of clinical trial activities.

  • Sub-investigator at CSL
    2024 - 2025 · 1 yr

    The Sub-Investigator (Sub-I) plays a key supporting role in the successful conduct of clinical trials by working under the supervision of the Principal Investigator (PI). In this capacity, the Sub-I ensures that the study is implemented in strict adherence to the protocol, Good Clinical Practice (GCP), ethical principles, and applicable regulatory requirements. The Sub-I may be entrusted with performing clinical evaluations, obtaining informed consent, and managing trial-related procedures to safeguard participant safety and data integrity. Equally important, the Sub-I contributes to the accurate and timely documentation of study findings, supporting the overall credibility of the research. Beyond clinical and administrative responsibilities, the Sub-I also assists in strengthening site-specific operational procedures and clinical algorithms, fostering efficiency, regulatory compliance, and continuous quality improvement at the trial site.

  • Sub-investigator at Yuxi Walvax Biotechnology Co., Ltd.
    2021 - 2025 · 4 yrs

    The Sub-Investigator (Sub-I) supports the Principal Investigator (PI) in the conduct of clinical trials, ensuring that the study is carried out according to the protocol, Good Clinical Practice (GCP), ethical standards, and regulatory requirements. The Sub-I may perform clinical evaluations, obtain informed consent, manage trial-related procedures, and contribute to the accurate and timely documentation of study data. Additionally, the Sub-I plays a special role in enhancing site-specific operational procedures and clinical algorithms to ensure efficiency, compliance, and continuous quality improvement at the trial site.

  • Sub-investigator at WANTAI BioPharm
    2021 - 2025 · 4 yrs

    The Sub-Investigator (Sub-I) supports the Principal Investigator (PI) in ensuring the effective and compliant conduct of clinical trials. The role is accountable for implementing study activities in accordance with the protocol, Good Clinical Practice (GCP), ethical standards, and regulatory requirements. Key responsibilities include performing clinical assessments, obtaining informed consent, managing trial-related procedures, and ensuring accurate and timely documentation of study data. In addition, the Sub-I contributes to strengthening site-specific operational workflows and clinical algorithms, driving efficiency, compliance, and continuous quality improvement to uphold the integrity and success of the trial.